Education
About Us
Working with TipRanks
Follow Us
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
OSL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.95 - AU$6.00
Previous CloseN/A
Volume350.23K
Average Volume (3M)16.13K
Market Cap
AU$11.29M
Enterprise ValueAU$4.33M
Total Cash (Recent Filing)AU$8.47M
Total Debt (Recent Filing)AU$70.84K
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding11,516,456
10 Day Avg. Volume18,320
30 Day Avg. Volume16,126
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.37
Price to Sales (P/S)0.00
P/FCF Ratio-1.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
OncoSil Medical Ltd News
PremiumCompany Announcements
OncoSil Medical Ltd Announces Extraordinary General Meeting
PremiumCompany Announcements
OncoSil Medical Completes Capital Consolidation to Strengthen Market Position
PremiumCompany Announcements
OncoSil Medical Ltd Launches Security Purchase Plan for Shareholders
PremiumCompany Announcements
OncoSil Medical Ltd Issues Over 1 Billion Shares to Bolster Capital
PremiumCompany Announcements
OncoSil Medical Announces Shareholder-Approved Security Consolidation
PremiumCompany Announcements
OncoSil Medical Ltd Announces Proposed Securities IssuePremiumCompany Announcements
OncoSil Medical Ltd Announces Proposed Securities IssuanceOSL FAQ
What was OncoSil Medical Ltd’s price range in the past 12 months?
OncoSil Medical Ltd lowest share price was AU$0.95 and its highest was AU$6.00 in the past 12 months.
What is OncoSil Medical Ltd’s market cap?
OncoSil Medical Ltd’s market cap is AU$11.29M.
When is OncoSil Medical Ltd’s upcoming earnings report date?
OncoSil Medical Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 76 days.
How were OncoSil Medical Ltd’s earnings last quarter?
OncoSil Medical Ltd released its earnings results on Feb 25, 2025. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is OncoSil Medical Ltd overvalued?
According to Wall Street analysts OncoSil Medical Ltd’s price is currently Overvalued.
Does OncoSil Medical Ltd pay dividends?
OncoSil Medical Ltd does not currently pay dividends.
What is OncoSil Medical Ltd’s EPS estimate?
OncoSil Medical Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoSil Medical Ltd have?
OncoSil Medical Ltd has 11,516,456 shares outstanding.
What happened to OncoSil Medical Ltd’s price movement after its last earnings report?
OncoSil Medical Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of OncoSil Medical Ltd?
Currently, no hedge funds are holding shares in AU:OSL
OncoSil Medical Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:OSL Sentiment 94%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-199.38%
Trailing 12-Months
Asset Growth
78.65%
Trailing 12-Months
Company Description
OncoSil Medical Ltd
OncoSil Medical Ltd (OSL) is a medical device company that operates within the biotechnology sector, focusing on innovative treatments for cancer patients. The company's core product is the OncoSil device, a brachytherapy technology designed to deliver targeted radiation therapy for the treatment of pancreatic cancer. OncoSil aims to improve the quality of life and survival rates for patients through its proprietary technology.